|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 | Opening the Door to Transcatheter Valves
The FDA recently gave market clearance for Medtronic’s Melody Transcatheter Pulmonary Valve, the first transcatheter valve approved in the United States. The cardiology...
|
|
 | Going the Hybrid Route
As cutting-edge technologies collide with innovative surgical and interventional treatments for multiple coronary or vascular issues, a hybrid approach is emerging as the...
|
|
|
|
 | ACC Highlights 30 Late-Breaking Trials
March 9, 2010 – The most recent data from 30 late-breaking clinical trials is being highlighted during the American College of Cardiology (ACC) 2010 scientific sessions,...
|
|
|
|
 | Save Time by Automating Charge Management
The Washington Hospital (TWH), a 239-bed not-for-profit community hospital in the highly competitive cardiac market of western Pennsylvania, gained an edge against the...
|
|
 | See the Signs of Heart Disease in Women
Atherosclerosis is the leading cause of cardiovascular disease (CAD), heart attacks and death in both men and women in the United States. However, advances in diagnosing...
|
|
|
|
 | Trends in 3D Visualization Software
As the volume of cardiovascular imaging procedures continues to grow, cardiology imaging IT is representing the fastest growth area for revenue among both the advanced...
|
|
Diagnostic & Invasive Cardiology Turns 50
Diagnostic & Invasive Cardiology (DAIC) is celebrating its 50th anniversary in 2010. It began as part of the broad coverage in Medical Electronics and Equipment News...
|
|
 | New Tools to Debulk Lesions
A recently introduced atherectomy catheter offers a new class of device. It offers the advantages of two cutting tips on the same catheter, the ability to bore through all...
|
|
|
|
|
|
 | Guiding Stent Treatment With FFR
Fractional flow reserve (FFR) is starting to change cardiologists’ minds about how to treat patients since the release of two-year results from the FAME (FFR vs....
|
|
|
|
 | Interventional Radiology Breaks New Ground
For more than a decade, Barry T. Katzen, M.D., medical director of Baptist Cardiac and Vascular Institute (BCVI) in Miami, Fla., has pioneered the integration of surgical...
|
|
|
|
|
|
 | Insights Into Cardiac Imaging for 2010
With new CPT reimbursement codes for cardiac computed tomography (CT) starting in January 2010, there will likely be renewed interest in CT this coming year.
This and...
|
|
 | Cardiac PET Adoption Gets a Boost
Our profession faces one of the most significant crises in its history,” said Michael Graham, M.D., president of the Society of Nuclear Medicine (SNM), regarding the...
|
|
|
|
 | The Cardiac Device Market Outlook for 2010
In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment – including events ranging from the 2006 BASKET-LATE trial...
|
|
|
|
|
|
|
|
 | Telemedicine – A New Type of House Call
The buzz words “access to healthcare” have recently been at the center of many political campaigns and government appropriations. However, to fully understand the...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 | New Trends in the ECG Monitoring
According to the American Heart Association (AHA), arrhythmias afflict more than 4 million patients and results in approximately half a million deaths each year in the...
|
|
|
|
|
|
 | New Methods to Detect Vulnerable Plaque
Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but there is extensive debate over which modalities are best...
|
|
 | New Designs May Ease Bifurcation Stenting
Stenting of lesions at coronary vessel bifurcations is one of the most challenging percutaneous interventions, along with a high risk of procedural complications and...
|
|
 | Advancements in Drug-Eluting Stents
Over the past year several new drug-eluting stents (DES) stents have been released and SYNTAX trial data proved DES compare as well as coronary artery bypass graft surgery...
|
|
|
|
 | DES Head in a New Direction
The polymer coating on drug-eluting stents (DES) used to carry the antiproliferative drugs cause an increased risk of stent thrombosis, months or even years after a stent...
|
|
|
|
